OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20

Nanoparticles in cancer diagnosis and treatment: Progress, challenges, and opportunities
Niloufar Rashidi, Majid Davidson, Vasso Apostolopoulos, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 95, pp. 105599-105599
Open Access | Times Cited: 19

Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14

Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs
Qi Zhao, Hong Zong, Pingping Zhu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11

N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1
Jing Li, Xiaohong Xu, Kaihao Xu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8

Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications
Penghui Li, Xiangjie Fang, Di Huang
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1

METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway
Runkun Liu, Guozhi Yin, Hang Tuo, et al.
Biology Direct (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 21

Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications
Xiaojuan Su, Yi Feng, Yi Qu, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 5, pp. 1121-1136
Open Access | Times Cited: 7

METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma
Jialin Wang, Mengxi Xiu, Jin Wang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7

A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia
Wei Zhou, Siying Li, Hong Wang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6

High N6‐methyladenosine‐activated TCEAL8 mRNA is a novel pancreatic cancer marker
Tomoaki Hara, Sikun Meng, Hiromichi Sato, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2360-2370
Open Access | Times Cited: 5

N6-methyladenosine modified circPAK2 promotes lymph node metastasis via targeting IGF2BPs/VEGFA signaling in gastric cancer
Pingan Ding, Hao‐Tian Wu, Jiaxiang Wu, et al.
Oncogene (2024) Vol. 43, Iss. 34, pp. 2548-2563
Closed Access | Times Cited: 5

Recent advances of m6A methylation in skeletal system disease
Jian‐Hui Liang, Qian Yi, Yang Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

The promoting effect of the POU3F2/METTL16/PFKM cascade on glycolysis and tumorigenesis of hepatocellular carcinoma
Ming Chen, Yuan Yang, Guangsheng Hu, et al.
Annals of Hepatology (2025), pp. 101776-101776
Open Access

Functions of METTL1/WDR4 and QKI as m7G modification - related enzymes in digestive diseases
Wenyan Zhou, Yan Yi, Wenyu Cao, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access

The interplay between RNA m<sup>6</sup>A modification and radiation biology of cancerous and non-cancerous tissues: a narrative review
Yajia Cheng, Yue Shang, S. Zhang, et al.
Cancer Biology and Medicine (2025) Vol. 21, Iss. 12, pp. 1120-1140
Open Access

Research progress on N6-methyladenosine RNA modification in osteosarcoma: functions, mechanisms, and potential clinical applications
Ying Yang, Wenjuan Ni, Yadong Yang, et al.
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access

METTL1 coordinates cutaneous squamous cell carcinoma progression via the m7G modification of the ATF4 mRNA
Xinru Zhang, Tong Chen, Fanrong Zhang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access

METTL1 Enhances RRP9 mRNA Stability Through m7G Modification to Drive Colorectal Tumorigenesis
Nan Li, Ying Jing, Long Xu, et al.
Molecular Carcinogenesis (2025)
Closed Access

The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes
Tongguo Shi, Huan Zhang, Yueqiu Chen
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access

RNA Modification in Metabolism
Yadi Liu, Zhongyan Sun, Dingkun Gui, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access

The METTL Family in Metabolic Disease Regulation
一鸣 刘
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 2020-2030
Closed Access

Page 1 - Next Page

Scroll to top